Permeation enhancer strategies in transdermal drug delivery

Harneet Marwah, Tarun Garg, Amit K. Goyal, Goutam Rath

Research output: Contribution to journalArticlepeer-review

361 Scopus citations


Today, ∼74% of drugs are taken orally and are not found to be as effective as desired. To improve such characteristics, transdermal drug delivery was brought to existence. This delivery system is capable of transporting the drug or macromolecules painlessly through skin into the blood circulation at fixed rate. Topical administration of therapeutic agents offers many advantages over conventional oral and invasive techniques of drug delivery. Several important advantages of transdermal drug delivery are prevention from hepatic first pass metabolism, enhancement of therapeutic efficiency and maintenance of steady plasma level of the drug. Human skin surface, as a site of drug application for both local and systemic effects, is the most eligible candidate available. New controlled transdermal drug delivery systems (TDDS) technologies (electrically-based, structure-based and velocity-based) have been developed and commercialized for the transdermal delivery of troublesome drugs. This review article covers most of the new active transport technologies involved in enhancing the transdermal permeation via effective drug delivery system.
Original languageEnglish (US)
Pages (from-to)564-578
Number of pages15
JournalDrug Delivery
Issue number2
StatePublished - Feb 12 2016
Externally publishedYes

Bibliographical note

Generated from Scopus record by KAUST IRTS on 2023-10-12


Dive into the research topics of 'Permeation enhancer strategies in transdermal drug delivery'. Together they form a unique fingerprint.

Cite this